transplantation

Documents about transplantation

• Kidney Transplantation#361151The ESRF Research Journal for Undergraduate Medical Students
• Heart Transplantation#361154The ESRF Research Journal for Undergraduate Medical Students
• Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation#827170ClinicalTrials.gov
• Global Survey of Corneal Transplantation and Eye Banking#10590OpenAlex
• Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation#154703ClinicalTrials.gov
• Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®#802957ClinicalTrials.gov
• CEUS in Kidney and Pancreas Transplantation#805296ClinicalTrials.gov
• Smoking after lung transplantation: Incidence and risk factors in the French multicenter prospective tabatransplant cohort study#250353HAL (France)
• Immuno-metabolism in nephrology and kidney transplantation#291772HAL (France)
• VEL-101 to Prevent Rejection After Kidney Transplantation#162404ClinicalTrials.gov
• HLA-DQ in Acute Kidney Transplantation Rejection#825992ClinicalTrials.gov
• Continuous Glucose Monitoring (CGM) After Kidney Transplantation#175065ClinicalTrials.gov
• Pharmacokinetic Study in the Biliary Complications During Liver Transplantation#172341ClinicalTrials.gov
• Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation#272293ClinicalTrials.gov
• Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation#363496ClinicalTrials.gov
• Sleep Disordered Breathing and Lung Transplantation#837762ClinicalTrials.gov
• Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen#832042ClinicalTrials.gov
• Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation#803701ClinicalTrials.gov
• Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin#803353ClinicalTrials.gov
• Efficacy and Safety of Fecal Microbiota Transplantation#195485ClinicalTrials.gov
• Mixed Chimeric Transplantation for Primary Amyloidosis#839329ClinicalTrials.gov
• Non-Invasive Rapid Assessment of Patients With Liver Transplants Using Magnetic Resonance Imaging With LiverMultiScan#835018ClinicalTrials.gov
• Cost-benefit analysis of deceased donor organ transplantation: an economic evaluation#28623bioRxiv / medRxiv
• Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)#442062ClinicalTrials.gov
• Relationship Between Numbers of Patients Registered and Procedures Performed at Lung Transplantation Centers in Japan#224960OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation#424324ClinicalTrials.gov
• Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation#836193ClinicalTrials.gov
• Fecal Transplantation to Eradicate Colonizing Emergent Superbugs#123511ClinicalTrials.gov
• Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation#136355ClinicalTrials.gov
• Validity of Different Prognostic Models Assessing 1 Year Survival After Liver Transplantation#807801ClinicalTrials.gov
• Rituximab for Prevention of Rejection After Renal Transplantation#834801ClinicalTrials.gov
• Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)#826602ClinicalTrials.gov
• Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation#123583ClinicalTrials.gov
• Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants#126026ClinicalTrials.gov
• Reparixin in Pancreatic Islet Transplantation#353405ClinicalTrials.gov
• Islet Transplantation Using Campath-1H and Infliximab Induction#805856ClinicalTrials.gov
• Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population#800684ClinicalTrials.gov
• Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation#807686ClinicalTrials.gov
• Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies#4545Europe PMC
• Incidence and risk factors for recurrent IgA nephropathy after kidney transplantation: A multicenter cohort study from Denmark#385433PLOS
• Severe Vanishing Bile Duct Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients#449011IRIS
• Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation#136327ClinicalTrials.gov
• Hair-follicle transplant as chronic skin ulcer treatment#335993RCAAP
• Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation#467653ClinicalTrials.gov
• Lung Segmental Perfusion Defect Is Associated With Airway Complications After Living-Donor Lobar Lung Transplantation#345345OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Prediction Model for PPCs in Patients Undergoing Lung Transplantation Using Machine Learning#826783ClinicalTrials.gov
• Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC#828278ClinicalTrials.gov
• Fecal Microbiota Transplantation for Refractory IgA Nephropathy#833142ClinicalTrials.gov
• Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques#800567ClinicalTrials.gov
• Donor Specific HLA Alloantibodies in Liver Transplantation#831990ClinicalTrials.gov

Related topics